Table 4.
Variables | P-value | HR | 95.0% CI for Exp(B) | P-value | HR | 95.0% CI for Exp(B) | P-value | HR | 95.0% CI for Exp(B) | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | Lower | Upper | Lower | Upper | |||||||
OS | DFS | LRRFS | ||||||||||
CRT vs. NCRT arm | 0.462 | 1.131 | 0.815 | 1.568 | 0.078 | 1.322 | 0.969 | 1.803 | 0.045 | 1.437 | 1.008 | 2.050 |
Age | 0.216 | 1.269 | 0.870 | 1.853 | 0.359 | 1.182 | 0.827 | 1.691 | 0.171 | 1.336 | .883 | 2.021 |
Site | 0.004 | 1.713 | 1.191 | 2.464 | 0.017 | 1.518 | 1.079 | 2.136 | 0.001 | 1.990 | 1.333 | 2.971 |
Cisplatin 200 mg | 0.368 | 1.204 | 0.804 | 1.805 | 0.475 | 1.155 | 0.778 | 1.714 | 0.625 | 1.122 | 0.707 | 1.781 |
Overall Stage | 0.015 | 0.566 | 0.358 | 0.894 | 0.072 | 0.686 | 0.454 | 1.034 | 0.202 | 0.743 | 0.471 | 1.173 |
rENE | 0.069 | 1.370 | 0.976 | 1.925 | 0.021 | 1.466 | 1.059 | 2.029 | 0.172 | 1.293 | 0.894 | 1.871 |
Bold values means statistically significant.